World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
99
Citations
38696
World Ranking
8552
National Ranking
4403

Timothy Vollmer publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Timothy Vollmer sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 421 publications — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Timothy Vollmer D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Timothy Vollmer sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 99 D-Index — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Timothy Vollmer is affiliated with the University of Florida in the United States. Their research primarily focuses on the field of medicine, with a substantial concentration on pathology and forensic medicine. Other subfields of study include neurology, oncology, immunology, and radiology, nuclear medicine, and imaging.

The main topics covered in their work include multiple sclerosis research studies, peripheral neuropathies and disorders, polyomavirus and related diseases, monoclonal and polyclonal antibodies research, health systems, economic evaluations, quality of life, toxin mechanisms and immunotoxins, and acute lymphoblastic leukemia research.

Timothy Vollmer has contributed to a range of publications with a total of 45 papers in medicine, including 13 on pathology and forensic medicine and 7 in neurology. Their articles have appeared in frequent venues such as:

  • Neurology
  • Multiple Sclerosis and Related Disorders
  • PLoS ONE
  • Journal of Neuroimmune Pharmacology
  • Multiple Sclerosis Journal

Some notable recent papers authored or co-authored by Vollmer include:

  • "Oligoclonal IgG antibodies in multiple sclerosis target patient-specific peptides," 2020, PLoS ONE
  • "Shorter infusion time of ocrelizumab: Results from the randomized, double-blind ENSEMBLE PLUS substudy in patients with relapsing-remitting multiple sclerosis," 2020, Multiple Sclerosis and Related Disorders
  • "Aberrant Immunoglobulin G Glycosylation in Multiple Sclerosis," 2021, Journal of Neuroimmune Pharmacology
  • "CONCERTO: A randomized, placebo-controlled trial of oral laquinimod in relapsing-remitting multiple sclerosis," 2021, Multiple Sclerosis Journal
  • "NARCOMS and Other Registries in Multiple Sclerosis," 2021, International Journal of MS Care

Frequent collaborators in Vollmer's research include Joep Killestein, Thomas Berger, Bruno Brochet, Trygve Holmøy, and Rana Karabudak.

Best Publications

  • B-cell depletion with rituximab in relapsing-remitting multiple sclerosis.

    Stephen L. Hauser;Emmanuelle Waubant;Douglas L. Arnold;Timothy Vollmer

  • Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosis Results of a phase III multicenter, double‐blind, placebo‐controlled trial

    K. P. Johnson;B. R. Brooks;J. A. Cohen;C. C. Ford

  • THE FUNCTIONS OF SELF‐INJURIOUS BEHAVIOR: AN EXPERIMENTAL‐EPIDEMIOLOGICAL ANALYSIS

    Brian A. Iwata;Gary M. Pace;Michael F. Dorsey;Jennifer R. Zarcone

  • Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial†

    Kathleen Hawker;Paul O'Connor;Mark S. Freedman;Peter A. Calabresi

  • Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial.

    Peter A. Calabresi;Ernst Wilhelm Radue;Douglas Goodin;Douglas Jeffery

  • Proposed diagnostic criteria and nosology of acute transverse myelitis

    G. Barnes;S. Benjamin;J. D. Bowen;N. Cutter

  • Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability

    Kenneth P. Johnson;B. R. Brooks;Jeffrey A Cohen;C. C. Ford

  • Prevalence and treatment of spasticity reported by multiple sclerosis patients

    M A Rizzo;O C Hadjimichael;J Preiningerova;T L Vollmer

  • Oral simvastatin treatment in relapsing-remitting multiple sclerosis.

    Timothy Vollmer;Lyndon Key;Valerie Durkalski;William Tyor;William Tyor

  • Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with parkinson’s disease

    Dennis D. Spencer;Dennis D. Spencer;Richard J. Robbins;Frederick Naftolin;Frederick Naftolin;Kenneth L. Marek;Kenneth L. Marek

  • Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis

    Ruth Ann M Marrie;R. Rudick;R. Horwitz;G. Cutter

  • Glatiramer acetate in primary progressive multiple sclerosis: Results of a multinational, multicenter, double-blind, placebo-controlled trial

    Jerry S. Wolinsky;Ponnada A. Narayana;Paul O'Connor;Patricia K. Coyle

  • Brain health: time matters in multiple sclerosis

    Gavin Giovannoni;Helmut Butzkueven;Suhayl Dhib-Jalbut;Jeremy Hobart

  • Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta

    Daniel Wynn;Michael Kaufman;Xavier Montalban;Timothy Vollmer

  • Employment in multiple sclerosis. Exiting and re-entering the work force.

    Laura J. Julian;Lea Vella;Tim Vollmer;Olympia Hadjimichael

  • Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years

    K. P. Johnson;B. R. Brooks;C. C. Ford;A. Goodman

  • Reliability and validity of two self-report measures of impairment and disability for MS

    C. E. Schwartz;T. Vollmer;Hang Lee

  • Treatment of Self-Injury and Hand Mouthing Following Inconclusive Functional Analyses.

    Timothy R. Vollmer;Bethany A. Marcus;Linda LeBlanc

  • Persistent pain and uncomfortable sensations in persons with multiple sclerosis.

    Olympia Hadjimichael;Robert D. Kerns;Marco A. Rizzo;Gary Cutter

  • Comorbidity delays diagnosis and increases disability at diagnosis in MS

    R. A. Marrie;R. Horwitz;G. Cutter;T. Tyry

Frequent Co-Authors

Gary Cutter
Gary Cutter University of Alabama at Birmingham
Fu-Dong Shi
Fu-Dong Shi Tianjin Medical University General Hospital
Ruth Ann Marrie
Ruth Ann Marrie University of Manitoba
Douglas L. Arnold
Douglas L. Arnold Montreal Neurological Institute and Hospital
Antonio La Cava
Antonio La Cava University of California, Los Angeles
Amit Bar-Or
Amit Bar-Or University of Pennsylvania
Eva Havrdova
Eva Havrdova Charles University
Carolyn E. Schwartz
Carolyn E. Schwartz Tufts University
Robert H. Roth
Robert H. Roth Yale University
Xavier Montalban
Xavier Montalban Autonomous University of Barcelona

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a career in Medicine but want flexible study options, there are several related online degrees to explore. For nurses looking to advance their qualifications, a range of affordable online programs now make this easier than ever.

Those interested in advanced practice may consider the cheapest online acute care nurse practitioner programs, which offer in-demand clinical skills and open doors to specialized healthcare roles. If you’re seeking to enter the nursing field quickly, the cheapest online accelerated bsn programs allow you to fast-track your Bachelor of Science in Nursing while balancing work or family commitments.

For registered nurses aiming to progress academically and take on research or leadership roles, several universities offer accredited online phd programs in nursing. Additionally, pursuing an RN to BSN qualification online can be a strategic move for career growth—learn more about rn to bsn online cost and program options available.

These flexible, affordable online pathways can help you advance your healthcare career while meeting personal and professional commitments.

Best Scientists Citing Timothy Vollmer

Trending Scientists

Recently Published Articles